• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双氢青蒿素衍生物经皮应用的抗疟活性。

Antimalarial activity of dihydroartemisinin derivatives by transdermal application.

作者信息

Lin A J, Ager A L, Klayman D L

机构信息

Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Washington, District of Columbia.

出版信息

Am J Trop Med Hyg. 1994 Jun;50(6):777-83. doi: 10.4269/ajtmh.1994.50.777.

DOI:10.4269/ajtmh.1994.50.777
PMID:8024074
Abstract

In addition to artelinic acid, which was demonstrated previously to possess good prophylactic as well as curative antimalarial activity against Plasmodium berghei by transdermal administration, seven artemisinin derivatives in a gel formulation were assessed for their antimalarial activities in this study. Artemisinin, the parent compound of the series, showed moderate prophylactic but poor curative activity. Although methyl artelinate was more active against P. berghei than artelinic acid and sodium artelinate by subcutaneous injection, its transdermal curative and prophylactic activity was only comparable with or weaker than that of artelinic acid. Conversely, both dihydroartemisinin trimethylsilyl ether and dehydrodihydroartemisinin showed weaker antimalarial activity than artelinic acid by the subcutaneous route, yet exhibited comparable activity by transdermal administration. Artemether, a prodrug of dihydroartemisinin, is as effective as the parent dihydroartemisinin, and both compounds were the most potent agents among the compounds studied, with total prophylactic and curative doses of 30 mg/kg and 60 mg/kg, respectively. Complete absorption of dihydroartemisinin appears to occur within 5 min after application. In general, we found that the prophylactic dose is about half that of the curative dose under the protocols used in this study. This novel drug delivery system may be an easy and safe way to administer artemisinin-type antimalarials and also a good alternative dosage form for active compounds with solubility problems.

摘要

除了先前已证明通过透皮给药对伯氏疟原虫具有良好预防和治疗抗疟活性的青蒿酸外,本研究还评估了凝胶制剂中的七种青蒿素衍生物的抗疟活性。该系列的母体化合物青蒿素显示出中等的预防活性,但治疗活性较差。虽然皮下注射时,青蒿甲酯对伯氏疟原虫的活性比青蒿酸和青蒿素钠更强,但其透皮治疗和预防活性仅与青蒿酸相当或比青蒿酸弱。相反,二氢青蒿素三甲基硅醚和脱氢二氢青蒿素通过皮下途径显示出比青蒿酸弱的抗疟活性,但通过透皮给药表现出相当的活性。双氢青蒿素的前药蒿甲醚与母体双氢青蒿素一样有效,这两种化合物是所研究化合物中最有效的药物,总预防剂量和治疗剂量分别为30mg/kg和60mg/kg。双氢青蒿素在给药后5分钟内似乎完全吸收。一般来说,我们发现在本研究使用的方案下,预防剂量约为治疗剂量的一半。这种新型药物递送系统可能是一种简单安全的青蒿素类抗疟药给药方式,也是具有溶解性问题的活性化合物的良好替代剂型。

相似文献

1
Antimalarial activity of dihydroartemisinin derivatives by transdermal application.双氢青蒿素衍生物经皮应用的抗疟活性。
Am J Trop Med Hyg. 1994 Jun;50(6):777-83. doi: 10.4269/ajtmh.1994.50.777.
2
Transdermal artelinic acid: an effective treatment for Plasmodium berghei-infected mice.
Am J Trop Med Hyg. 1991 Nov;45(5):602-7. doi: 10.4269/ajtmh.1991.45.602.
3
Plasmodium berghei: the antimalarial action of artemisinin and sodium artelinate in vivo and in vitro, studied by flow cytometry.伯氏疟原虫:通过流式细胞术研究青蒿素和青蒿琥酯在体内和体外的抗疟作用。
Exp Parasitol. 1990 Feb;70(2):115-23. doi: 10.1016/0014-4894(90)90092-q.
4
Antimalarial activity of new dihydroartemisinin derivatives. 7. 4-(p-substituted phenyl)-4(R or S)-[10(alpha or beta)-dihydroartemisininoxy]butyric acids.
J Med Chem. 1997 Apr 25;40(9):1396-400. doi: 10.1021/jm9607919.
5
Comparison of in vivo and in vitro antimalarial activity of artemisinin, dihydroartemisinin and sodium artesunate in the Plasmodium berghei-rodent model.青蒿素、双氢青蒿素和青蒿琥酯钠在伯氏疟原虫-啮齿动物模型中的体内和体外抗疟活性比较。
Int J Parasitol. 1994 Jul;24(4):589-94. doi: 10.1016/0020-7519(94)90150-3.
6
Antimalarial activity of new water-soluble dihydroartemisinin derivatives.
J Med Chem. 1987 Nov;30(11):2147-50. doi: 10.1021/jm00394a037.
7
Antimalarial activity of new dihydroartemisinin derivatives. 5. Sugar analogues.新型双氢青蒿素衍生物的抗疟活性。5. 糖类类似物。
J Med Chem. 1992 May 1;35(9):1639-42. doi: 10.1021/jm00087a021.
8
Antimalarial activity of new dihydroartemisinin derivatives. 6. alpha-Alkylbenzylic ethers.
J Med Chem. 1995 Mar 3;38(5):764-70. doi: 10.1021/jm00005a004.
9
Comparison of beta-artemether and beta-arteether against malaria parasites in vitro and in vivo.蒿甲醚和蒿乙醚在体外和体内对疟原虫的比较。
Am J Trop Med Hyg. 1993 Mar;48(3):377-84. doi: 10.4269/ajtmh.1993.48.377.
10
Antimalarial activity of novel ring-contracted artemisinin derivatives.新型环缩青蒿素衍生物的抗疟活性
J Med Chem. 1995 May 26;38(11):1922-7. doi: 10.1021/jm00011a012.

引用本文的文献

1
Evaluating the activity of N-89 as an oral antimalarial drug.评估 N-89 作为口服抗疟药物的活性。
Parasites Hosts Dis. 2023 Aug;61(3):282-291. doi: 10.3347/PHD.23044. Epub 2023 Aug 21.
2
Drug Development Strategies for Malaria: With the Hope for New Antimalarial Drug Discovery-An Update.疟疾的药物开发策略:寄望于新型抗疟药物的发现——最新进展
Adv Med. 2023 Mar 14;2023:5060665. doi: 10.1155/2023/5060665. eCollection 2023.
3
Are various Babesia species a missed cause for hypereosinophilia? A follow-up on the first reported case of imatinib mesylate for idiopathic hypereosinophilia.
各种巴贝斯虫属物种会是嗜酸性粒细胞增多症被漏诊的病因吗?对首例甲磺酸伊马替尼治疗特发性嗜酸性粒细胞增多症报道病例的随访。
MedGenMed. 2007 Feb 27;9(1):38.